Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Hyung Joon Yim, Seong Gyu Hwang
Clin Mol Hepatol. 2013;19(3):195-209.   Published online 2013 Sep 30     DOI: https://doi.org/10.3350/cmh.2013.19.3.195
Citations to this article as recorded by Crossref logo
Treatment Algorithm for Managing Chronic Hepatitis B Virus Infection in the United States: 2021 Update
Paul Martin, Mindie H. Nguyen, Douglas T. Dieterich, Daryl T.-Y. Lau, Harry L.A. Janssen, Marion G. Peters, Ira M. Jacobson
Clinical Gastroenterology and Hepatology.2022; 20(8): 1766.     CrossRef
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study
Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Journal of Viral Hepatitis.2022; 29(9): 756.     CrossRef
How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review
Chan Keat Kang, Paul N Brennan, John F Dillon
Clinical Interventions in Aging.2022; Volume 17: 1811.     CrossRef
Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B
Young Eun Ahn, Sang Jun Suh, Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
The Korean Journal of Gastroenterology.2021; 77(1): 22.     CrossRef
Companion and complementary diagnostics for infectious diseases
Peter J. Dailey, Tarek Elbeik, Mark Holodniy
Expert Review of Molecular Diagnostics.2020; 20(6): 619.     CrossRef
Tenofovir‐based combination therapy or monotherapy for multidrug‐resistant chronic hepatitis B: Long‐term data from a multicenter cohort study
Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Seong Gyu Hwang, Yeon Seok Seo, Soon Ho Um, Sae Hwan Lee, Young Seok Kim, Jae Young Jang, In Hee Kim, Hyoung Su Kim, Ji Hoon Kim, Young Sun Lee, Eileen L. Yoon, Myeong Jun Song, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(12): 1306.     CrossRef
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee
Clinical and Molecular Hepatology.2020; 26(4): 411.     CrossRef
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2019; 25(2): 93.     CrossRef
2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants
Uma S. Singh, Varughese A. Mulamoottil, Chung K. Chu
Medicinal Research Reviews.2018; 38(3): 977.     CrossRef
Direct Detection of Drug-Resistant Hepatitis B Virus in Serum Using a Dendron-Modified Microarray
Doo Hyun Kim, Hong Seok Kang, Seong-Suk Hur, Seobo Sim, Sung Hyun Ahn, Yong Kwang Park, Eun-Sook Park, Ah Ram Lee, Soree Park, So Young Kwon, Jeong-Hoon Lee, Kyun-Hwan Kim
Gut and Liver.2018; 12(3): 331.     CrossRef
The management of hepatitis B and hepatitis C in children
Irini D. Batsis, Paul Wasuwanich, Wikrom W. Karnsakul
Minerva Pediatrica.2018;[Epub]     CrossRef
Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
Eun Young Cho, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Yeon Seok Seo, Ji Hoon Kim, Hong Soo Kim, Sae Hwan Lee, Sang Hoon Ahn, Jeong Il Lee, Sook-Hyang Jeong, Jin-Wook Kim, Jin-Woo Lee, In Hee Kim, Hyoung Su Kim, Sang Jong Park, Jeong Mi Lee, Seong G
Gut and Liver.2017; 11(1): 129.     CrossRef
The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors
Zhi-Qin Li, Chun-Ling Hu, Ping Yu, Xin-Yu Gu, Jia-Jia Zhang, Hua Li, Hong-Yu Zhang, Jun Lv, Yan-Min Liu, Qing-Lei Zeng, Jing-Ya Yan, Zu-Jiang Yu, Yi Zhang
Clinics and Research in Hepatology and Gastroenterology.2017; 41(3): 311.     CrossRef
Aligning to the sample-specific reference sequence to optimize the accuracy of next-generation sequencing analysis for hepatitis B virus
Wen-Chun Liu, Chih-Peng Lin, Chun-Pei Cheng, Cheng-Hsun Ho, Kuo-Lun Lan, Ji-Hong Cheng, Chia-Jui Yen, Pin-Nan Cheng, I-Chin Wu, I-Chen Li, Bill Chia-Han Chang, Vincent S. Tseng, Yen-Cheng Chiu, Ting-Tsung Chang
Hepatology International.2016; 10(1): 147.     CrossRef
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
Dorota Kozielewicz, Waldemar Halota, Magdalena Wietlicka-Piszcz
Hepatology International.2016; 10(2): 302.     CrossRef
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clinical and Molecular Hepatology.2016; 22(2): 238.     CrossRef
Entecavir plus tenofovir combination therapy in patients with multidrug‐resistant chronic hepatitis B: results of a multicentre, prospective study
Jun Yong Park, Chang Wook Kim, Si Hyun Bae, Kyu Sik Jung, Hee Yeon Kim, Seung Kew Yoon, Kwang‐Hyub Han, Sang Hoon Ahn
Liver International.2016; 36(8): 1108.     CrossRef
Identification of UQCRB as an oxymatrine recognizing protein using a T7 phage display screen
Yan-hui Sun, Xiao-yuan Zhang, Wei-qun Xie, Guang-jian Liu, Xi-xin He, Ya-li Huang, Guang-xian Zhang, Jian Wang, Zao-yuan Kuang, Ren Zhang
Journal of Ethnopharmacology.2016; 193: 133.     CrossRef
Efficacy of telbivudine compared with entecavir in hepatitis B virus‐related cirrhosis: 2 year follow‐up data
Hae Rim Kim, Hyung Joon Yim, Seonghee Kang, Sang Jun Suh, Seung Young Kim, Jong Jin Hyun, Ja Seol Koo, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Sang Woo Lee, Kwan Soo Byun, Soon Ho Um
Liver International.2015; 35(3): 860.     CrossRef
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
Paul Martin, Daryl T.-Y. Lau, Mindie H. Nguyen, Harry L.A. Janssen, Douglas T. Dieterich, Marion G. Peters, Ira M. Jacobson
Clinical Gastroenterology and Hepatology.2015; 13(12): 2071.     CrossRef
Substitution at rt269 in Hepatitis B Virus Polymerase Is a Compensatory Mutation Associated with Multi-Drug Resistance
Sung Hyun Ahn, Doo Hyun Kim, Ah Ram Lee, Beom Kyung Kim, Yong Kwang Park, Eun-Sook Park, Sang Hoon Ahn, Gu-Choul Shin, Soree Park, Hong Seok Kang, Jin-Kyu Rhee, Sung-Il Yang, Youhoon Chong, Kyun-Hwan Kim, Jason Blackard
PLOS ONE.2015; 10(8): e0136728.     CrossRef
Management of entecavir-resistant chronic hepatitis B with adefovir-based combination therapies
Hyoung Su Kim
World Journal of Gastroenterology.2015; 21(38): 10874.     CrossRef
Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B
Seong Hee Kang, Hyung Joon Yim, Hae Rim Kim, Keunhee Kang, Sang Jun Suh, Hyun Jung Lee, Eileen L. Yoon, Ji Hoon Kim, Yeon Seok Seo, Jong Eun Yeon, Kwan Soo Byun
Journal of Clinical Gastroenterology.2014; 48(10): 889.     CrossRef
Oral antiviral agents for treatment of chronic hepatitis B
Soon Young Ko, Won Hyeok Choe
Journal of the Korean Medical Association.2014; 57(1): 60.     CrossRef